Book contents
- Practical Psychopharmacology
- Practical Psychopharmacology
- Copyright page
- Dedication
- Contents
- Foreword
- Preface
- Abbreviations
- Part I General Principles
- 1 Core Concepts of Good Psychopharmacology
- 2 Targets of Treatment: Categories versus Dimensions of Psychopathology
- 3 Interpreting and Using the Literature: Integrating Evidence-Based Trials with Real-World Practice
- 4 Placebo and Nocebo Effects
- 5 Tailoring the Fit: Moderators and Mediators of Treatment Outcome
- 6 Complex Regimens and Rationale-Based Combination Drug Therapies
- 7 Laboratory Values and Psychiatric Symptoms: What to Measure, What Not to Measure, and What to Do With The Results
- 8 Pharmacogenetics: When Relevant, When Not
- 9 Cross-tapering and the Logistics of Drug Discontinuation
- 10 Managing Major Adverse Drug Effects: When to Avoid, Switch, or Treat Through
- 11 Novel Drug Therapeutics: Nutraceuticals, Steroids, Probiotics, and Other Dietary Supplements
- 12 Human Diversity and Considerations in Special Populations
- Part II Targets of Pharmacotherapy
- References
- Index
3 - Interpreting and Using the Literature: Integrating Evidence-Based Trials with Real-World Practice
from Part I - General Principles
Published online by Cambridge University Press: 19 October 2021
- Practical Psychopharmacology
- Practical Psychopharmacology
- Copyright page
- Dedication
- Contents
- Foreword
- Preface
- Abbreviations
- Part I General Principles
- 1 Core Concepts of Good Psychopharmacology
- 2 Targets of Treatment: Categories versus Dimensions of Psychopathology
- 3 Interpreting and Using the Literature: Integrating Evidence-Based Trials with Real-World Practice
- 4 Placebo and Nocebo Effects
- 5 Tailoring the Fit: Moderators and Mediators of Treatment Outcome
- 6 Complex Regimens and Rationale-Based Combination Drug Therapies
- 7 Laboratory Values and Psychiatric Symptoms: What to Measure, What Not to Measure, and What to Do With The Results
- 8 Pharmacogenetics: When Relevant, When Not
- 9 Cross-tapering and the Logistics of Drug Discontinuation
- 10 Managing Major Adverse Drug Effects: When to Avoid, Switch, or Treat Through
- 11 Novel Drug Therapeutics: Nutraceuticals, Steroids, Probiotics, and Other Dietary Supplements
- 12 Human Diversity and Considerations in Special Populations
- Part II Targets of Pharmacotherapy
- References
- Index
Summary
When investigators report the findings from a clinical trial, the results require interpretation. Peer review is the process through which the structure and execution of a clinical study is judged to be coherent, linear, and logical. The procedure is not unlike conducting a mental status exam: the evaluator is trying to discern if the content is credible at face value, if any underlying factors that could be biasing the results are accounted for, if the observed phenomena are being interpreted accurately, and if the conclusions drawn are valid. With varying degrees of provisionality or certainty, clinical trials give information about the narrow impact of (usually) one intervention versus a comparator (a placebo; an active comparator; or treatment as usual (TAU)) for a circumscribed period of time, with efforts made to hold other relevant variables constant (so, no other treatments are begun or altered, adherence must be near-perfect, substance use is grounds for ejection, and major life disruptions could botch the findings).
- Type
- Chapter
- Information
- Practical PsychopharmacologyTranslating Findings From Evidence-Based Trials into Real-World Clinical Practice, pp. 47 - 72Publisher: Cambridge University PressPrint publication year: 2021